Amprius Technologies vs CBAK Energy Technology
AMPX and CBAT side by side, both in electronic and other electrical equipment and components, except computer equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AMPX and CBAT compare
Amprius Technologies is the larger company, worth 13 times as much as CBAK Energy Technology ($1.2B against $93.1M).
Amprius Technologies grew revenue faster over the last twelve months (117% versus 50.5% for CBAK Energy Technology).
CBAK Energy Technology keeps more of each dollar of sales as profit, with a net margin of −7.4% compared with −28.4% at Amprius Technologies.
Amprius Technologies scores higher on the StockData Score (12 against 7 for CBAK Energy Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AMPX | CBAT |
|---|---|---|
| Size and price | ||
| Market cap | $1.2B | $93.1M |
| Share price | $8.55 | $1.05 |
| Change, 1 year | −37.1% | 13.6% |
| Change, 5 years | – | −50.7% |
| Beta (5Y) | 1.97 | 1.17 |
| Employees | 97 | 1,739 |
| StockData Score | ||
| Total score | 12 (better) | 7 |
| Valuation score | 0 | 3 (better) |
| Growth score | 4 (better) | 1 |
| Performance score | 2 | 2 |
| Health score | 6 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 9.8× | 0.4× (better) |
| P/B | 10.0× | 0.9× (better) |
| P/FCF | – | 2.5× |
| FCF yield | −4.9% | 39.4% (better) |
| Fair value | $6.53 | $2.68 |
| Margin of safety | −30.9% | 60.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 117% (better) | 50.5% |
| Revenue growth, 5Y average | – | 39.0% |
| Net income growth (TTM) | – | −4664% |
| Profitability | ||
| Gross margin | 24.8% (better) | 6.4% |
| Operating margin | −32.4% | −11.0% (better) |
| Net margin | −28.4% | −7.4% (better) |
| FCF margin | −48.7% | 16.0% (better) |
| Return on equity | −31.7% | −15.1% (better) |
| Return on invested capital | −69.2% | −16.5% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.43 (better) |
| Interest coverage | – | −22.4× |
| Current ratio | 4.21 (better) | 0.65 |
| Altman Z-score | 17.76 (better) | −0.28 |
| Piotroski F-score | 6 (better) | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 66.7% | – |
| Held by insiders | 7.5% | 0.00% |
| Insider net buying, 12 months | −$74.1M | – |
| Short interest, % of float | 16.1% | 0.71% |
Go deeper
- AMPX stock overview
- AMPX income statement
- AMPX valuation and score
- CBAT stock overview
- CBAT income statement
- CBAT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.